Protagenic Therapeutics, Inc.\new (PTIX) Capital expenditures 2015–2016
Protagenic Therapeutics, Inc.\new (PTIX) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$1,791FY2016 · since FY2015: $1,000 → $1,791
| Fiscal year | Value | YoY |
|---|---|---|
| FY2016 | $1,791 | +79.1% |
| FY2015 | $1,000 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice